one) and Drug Interactions (7)]. The risk of hypoglycemia could possibly be lowered by a reduction in the dose of sulfonylurea (or other concomitantly administered insulin secretagogue) or insulin. Notify clients working with these concomitant medicines of the potential risk of hypoglycemia and educate them within the indicators and symptoms of hyp